Annual Accounts Payable
$4.93 M
+$2.00 M+68.32%
September 30, 2024
Summary
- As of February 22, 2025, CTXR annual accounts payable is $4.93 million, with the most recent change of +$2.00 million (+68.32%) on September 30, 2024.
- During the last 3 years, CTXR annual accounts payable has risen by +$3.65 million (+285.81%).
- CTXR annual accounts payable is now at all-time high.
Performance
CTXR Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$7.36 M
+$2.44 M+49.46%
December 31, 2024
Summary
- As of February 22, 2025, CTXR quarterly accounts payable is $7.36 million, with the most recent change of +$2.44 million (+49.46%) on December 31, 2024.
- Over the past year, CTXR quarterly accounts payable has increased by +$5.70 million (+342.74%).
- CTXR quarterly accounts payable is now at all-time high.
Performance
CTXR Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
CTXR Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +68.3% | +342.7% |
| 3 y3 years | +285.8% | +342.7% |
| 5 y5 years | +81.6% | +342.7% |
CTXR Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +322.8% | at high | +531.9% |
| 5 y | 5-year | at high | +322.8% | at high | +648.2% |
| alltime | all time | at high | -100.0% | at high | -100.0% |
Citius Pharmaceuticals Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | - | $7.36 M(+49.5%) |
| Sep 2024 | $4.93 M(+68.3%) | $4.93 M(+196.2%) |
| Jun 2024 | - | $1.66 M(-37.7%) |
| Mar 2024 | - | $2.67 M(+0.8%) |
| Dec 2023 | - | $2.65 M(-9.6%) |
| Sep 2023 | $2.93 M(+151.2%) | $2.93 M(-4.9%) |
| Jun 2023 | - | $3.08 M(+13.0%) |
| Mar 2023 | - | $2.73 M(+77.3%) |
| Dec 2022 | - | $1.54 M(+31.9%) |
| Sep 2022 | - | $1.17 M(-31.1%) |
| Sep 2022 | $1.17 M(-8.7%) | - |
| Jun 2022 | - | $1.69 M(-0.9%) |
| Mar 2022 | - | $1.71 M(-4.7%) |
| Dec 2021 | - | $1.79 M(+40.1%) |
| Sep 2021 | $1.28 M(-31.2%) | $1.28 M(-5.7%) |
| Jun 2021 | - | $1.35 M(+19.6%) |
| Mar 2021 | - | $1.13 M(+15.1%) |
| Dec 2020 | - | $984.20 K(-47.0%) |
| Sep 2020 | $1.86 M(-31.6%) | $1.86 M(+2.5%) |
| Jun 2020 | - | $1.81 M(+18.8%) |
| Mar 2020 | - | $1.52 M(-1.5%) |
| Dec 2019 | - | $1.55 M(-43.0%) |
| Sep 2019 | $2.71 M(+72.5%) | $2.71 M(+11.6%) |
| Jun 2019 | - | $2.43 M(+26.2%) |
| Mar 2019 | - | $1.93 M(-7.6%) |
| Dec 2018 | - | $2.08 M(+32.4%) |
| Sep 2018 | $1.57 M | $1.57 M(+72.5%) |
| Jun 2018 | - | $912.30 K(-34.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2018 | - | $1.40 M(+149.6%) |
| Dec 2017 | - | $561.20 K(-6.8%) |
| Sep 2017 | $602.40 K(-33.7%) | $602.40 K(-69.5%) |
| Jun 2017 | - | $1.98 M(+6.2%) |
| Mar 2017 | - | $1.86 M(+89.0%) |
| Dec 2016 | - | $985.90 K(+8.4%) |
| Sep 2016 | $909.20 K(+62.6%) | $909.20 K(+194.0%) |
| Jun 2016 | - | $309.20 K(-15.7%) |
| Mar 2016 | - | $366.70 K(-20.1%) |
| Dec 2015 | - | $458.70 K(-18.0%) |
| Sep 2015 | $559.20 K(+426.6%) | $559.20 K(+67.3%) |
| Jun 2015 | - | $334.30 K(-2.6%) |
| Mar 2015 | - | $343.40 K(+72.5%) |
| Dec 2014 | - | $199.10 K(+87.5%) |
| Sep 2014 | $106.20 K(+823.5%) | $106.20 K(+6980.0%) |
| Jun 2014 | - | $1500.00(+200.0%) |
| Mar 2014 | - | $500.00(+150.0%) |
| Dec 2013 | - | $200.00(-98.3%) |
| Sep 2013 | $11.50 K(>+9900.0%) | $11.50 K(+2775.0%) |
| Jun 2013 | - | $400.00(+100.0%) |
| Mar 2013 | - | $200.00(-66.7%) |
| Dec 2012 | - | $600.00(>+9900.0%) |
| Sep 2012 | $0.00(-100.0%) | $0.00(-100.0%) |
| Jun 2012 | - | $900.00(0.0%) |
| Mar 2012 | - | $900.00(0.0%) |
| Dec 2011 | - | $900.00(0.0%) |
| Sep 2011 | $900.00 | $900.00(0.0%) |
| Jun 2011 | - | $900.00 |
FAQ
- What is Citius Pharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for Citius Pharmaceuticals?
- What is Citius Pharmaceuticals annual accounts payable year-on-year change?
- What is Citius Pharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for Citius Pharmaceuticals?
- What is Citius Pharmaceuticals quarterly accounts payable year-on-year change?
What is Citius Pharmaceuticals annual accounts payable?
The current annual accounts payable of CTXR is $4.93 M
What is the all time high annual accounts payable for Citius Pharmaceuticals?
Citius Pharmaceuticals all-time high annual accounts payable is $4.93 M
What is Citius Pharmaceuticals annual accounts payable year-on-year change?
Over the past year, CTXR annual accounts payable has changed by +$2.00 M (+68.32%)
What is Citius Pharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of CTXR is $7.36 M
What is the all time high quarterly accounts payable for Citius Pharmaceuticals?
Citius Pharmaceuticals all-time high quarterly accounts payable is $7.36 M
What is Citius Pharmaceuticals quarterly accounts payable year-on-year change?
Over the past year, CTXR quarterly accounts payable has changed by +$5.70 M (+342.74%)